Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO).

about

Waldenström macroglobulinemia treatment algorithm 2018.

P2860

Q55018872-6B07FACB-AAF2-49CA-86BE-05647FD77071

P2860

Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO).

Item

http://www.wikidata.org/entity/Q38645082

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Transformed Waldenström macrog ...... Leukemia Organization (FILO).

@en

type

Item

label

Transformed Waldenström macrog ...... Leukemia Organization (FILO).

@en

prefLabel

Transformed Waldenström macrog ...... Leukemia Organization (FILO).

@en

P1476

Transformed Waldenström macrog ...... e Leukemia Organization (FILO)

@en

P2093

Alain Delmer

http://www.w3.org/2001/XMLSchema#string

Anne-Sophie Michallet

http://www.w3.org/2001/XMLSchema#string

Aurore Perrot

http://www.w3.org/2001/XMLSchema#string

Bénédicte Hivert

http://www.w3.org/2001/XMLSchema#string

Caroline Regny

http://www.w3.org/2001/XMLSchema#string

Cécile Tomowiak

http://www.w3.org/2001/XMLSchema#string

Elise Toussaint

http://www.w3.org/2001/XMLSchema#string

Eric Van Den Neste

http://www.w3.org/2001/XMLSchema#string

Fatiha Merabet

http://www.w3.org/2001/XMLSchema#string

Jean-Marc Zini

http://www.w3.org/2001/XMLSchema#string

P2860

Transformed follicular non-Hodgkin lymphoma

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas.

Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation.

Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop.

Richter syndrome: pathogenesis and management.

Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database.

Immunoblastic sarcoma following Waldenström's macroglobulinemia.

P304

439-448

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.14881

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

179

http://www.w3.org/2001/XMLSchema#string

P50

Eric Durot

P577

2017-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28770576

http://www.w3.org/2001/XMLSchema#string

Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO).

about

P2860

P2860

Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698